Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	349438-38-6
Formula :	C₁₅H₁₁Cl₂NO₃
M.W :	324.16
SMILES Code :	O=C(NCC1=CC=C(OCO2)C2=C1)C3=C(Cl)C=CC=C3Cl
MDL No. :	MFCD02055160
InChI Key :	NMKJFZCBCIUYHI-UHFFFAOYSA-N
Pubchem ID :	831629

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H301-H400
Precautionary Statements:	P273-P301+P310
Class:	6.1
UN#:	2811
Packing Group:	Ⅲ

Recombinant ALDH2	20 µM	1 hour	Alda-1 prevented nitroglycerin-induced ALDH2 inactivation	Sci Transl Med. 2011 Nov 2;3(107):107ra111.
H9c2 cells	20 µM	12 hours	Alda-1 treatment significantly increased ALDH2 activation in H9c2 cells and promoted mitochondrial respiration.	Bioact Mater. 2021 Jan 8;6(7):2058-2069.
Cardiomyocytes	20 µM	12 hours	Alda-1 treatment significantly increased ALDH2 activation in cardiomyocytes and promoted mitochondrial respiration.	Bioact Mater. 2021 Jan 8;6(7):2058-2069.
T84 human colon cells	20 µM	12 hours	Alda-1 restored the levels of ALDH2 protein and activity, and significantly blocked ethanol-induced increase in cell permeability and reduction in TJ/AJ protein levels.	Redox Biol. 2023 Feb;59:102577.
A549 cells	0 nM, 100 nM, 350 nM, 1 µM	2 days	Alda-1 treatment significantly reduced the side population of A549 cells, indicating that Alda-1 inhibits the stem cell-like properties of lung cancer cells.	Neoplasia. 2019 Jun;21(6):602-614.
H1299 cells	0 nM, 100 nM, 1 µM	2 days	Alda-1 treatment significantly reduced the CD44+/CD24− population of H1299 cells, indicating that Alda-1 inhibits the stem cell-like properties of lung cancer cells.	Neoplasia. 2019 Jun;21(6):602-614.
H9C2 cells	20 µM	2 hours	To evaluate the protective effect of Alda-1 on LPS-induced apoptosis and inflammation in H9C2 cells, the results showed that Alda-1 pretreatment significantly reduced LPS-induced mitochondrial membrane permeability, ROS levels, and apoptosis rate, and decreased the expression of inflammatory factors.	Mol Med. 2023 Dec 20;29(1):171.
H9C2 myoblasts	20 µM	24 hours	To evaluate the protective effect of Alda-1 on Aβ-induced lipid peroxidation, results showed that Alda-1 significantly alleviated Aβ-induced lipid peroxidation.	Acta Pharmacol Sin. 2022 Jan;43(1):39-49.
Human renal proximal tubular epithelial cells (HK-2)	20 µM	24 hours	To evaluate the effect of Alda-1 on MA-induced mitochondrial dysfunction and apoptosis in HK-2 cells. Results showed that Alda-1 treatment significantly improved mitochondrial function and reduced apoptosis.	Cell Death Dis. 2023 Jan 20;14(1):45.
3T3 cells	20 µM	48 hours	Evaluate the activation effect of Alda-1 on ALDH2 variants. The results showed that Alda-1 increased the activity of the ALDH2*2 variant by approximately 14-fold, but had limited activation effects on other variants.	EBioMedicine. 2020 May;55:102753.
Human-derived fibroblasts	20 µM	48 hours	Evaluate the activation effect of Alda-1 on ALDH2 variants. The results showed that Alda-1 had poor activation effects on ALDH23 and ALDH26 variants, and did not significantly improve their activity.	EBioMedicine. 2020 May;55:102753.
Cardiac fibroblasts	20 µM	96 hours	Alda-1 treatment reduced fibroblast proliferation under aldehydic load stress	Cardiovasc Res. 2014 Sep 1;103(4):498-508.
ALDH2*1	0.03–0.06 µM		To study the activation effect of Alda-1 on ALDH2*1 dehydrogenase activity	Nat Struct Mol Biol. 2010 Feb;17(2):159-64.
ALDH2*2	0.3–0.5 µM		To study the activation effect of Alda-1 on ALDH2*2 dehydrogenase activity	Nat Struct Mol Biol. 2010 Feb;17(2):159-64.
HepG2 cells	40 µM		Alda-1 prevented HNE-induced HepG2 cell death by activating ALDH2 to degrade HNE	Cell Mol Gastroenterol Hepatol. 2022;14(4):925-944.
Huh-7 cells	40 µM		Alda-1 prevented HNE-induced Huh-7 cell death by activating ALDH2 to degrade HNE	Cell Mol Gastroenterol Hepatol. 2022;14(4):925-944.

{[proInfo.proName]}

CAS No.: 349438-38-6

{[proInfo.proName]}

CAS No.: 349438-38-6

Alternative Products

Product Details of Alda-1

Safety of Alda-1

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

C57BL/6 mice	LPS-induced myocardial injury model	Intraperitoneal injection	10 mg/kg	Single injection, lasting 12 hours	To evaluate the protective effect of Alda-1 on LPS-induced cardiac dysfunction, inflammation, and apoptosis, the results showed that Alda-1 pretreatment significantly improved cardiac function, reduced the expression of cardiac injury markers CKMB and LDH, and decreased the levels of inflammatory cytokines and apoptosis rate.	Mol Med. 2023 Dec 20;29(1):171.
C57BL/6 mice	Intestinal ischemia-reperfusion injury model	Intraperitoneal injection	10 mg/kg	Single dose, 1 hour before ischemia	Alda-1 pretreatment significantly alleviated intestinal ischemia-reperfusion injury, accompanied by up-regulated ALDH2 activity and reduced accumulation of 4-HNE and MDA.	Clin Sci (Lond). 2017 Jun 1;131(11):1123-1136
Rats	Myocardial infarction-induced heart failure model	Subcutaneous injection	10 mg/kg/day	Continuous for 6 weeks	Alda-1 treatment improved cardiac function, reduced left ventricular dilation, and decreased myocardial hypertrophy and cardiac fibrosis	Cardiovasc Res. 2014 Sep 1;103(4):498-508.
Wistar rats	Myocardial infarction model	Continuous infusion via Alzet pump	16 mg/kg/day	16 hours	Alda-1 prevented nitroglycerin-induced increase in myocardial infarction injury	Sci Transl Med. 2011 Nov 2;3(107):107ra111.
Mice and rats	ALDH21/2 knock-in mice and Wistar rats	Subcutaneous injection	2 mg/kg	15 minutes before, and again at 30 and 150 minutes after	Alda-1 reduced the response to nociceptive stimulus in ALDH21/2 mice and reversed the carrageenan-induced pain behavior, restoring thresholds to baseline values for both wild type and ALDH21/2 mice.	Sci Transl Med. 2014 Aug 27;6(251):251ra118
Mice	Choline-deficient, amino acid-defined (CDAA) mouse model	Intraperitoneal injection	20 mg/kg	3 times a week for 8 weeks	Alda-1 reduced liver inflammation and fibrosis by degrading HNE	Cell Mol Gastroenterol Hepatol. 2022;14(4):925-944.
C57BL/6 mice	Cisplatin or maleic acid-induced acute kidney injury model	Intraperitoneal injection	20 mg/kg	Once daily for 3 days	To evaluate the protective effect of Alda-1 on cisplatin or maleic acid-induced acute kidney injury. Results showed that Alda-1 pretreatment significantly improved renal function and reduced tubular injury and apoptosis.	Cell Death Dis. 2023 Jan 20;14(1):45.
C57BL/6 mice	Bile duct ligation model	Subcutaneous injection	20 mg/kg	Once daily for 14 days	Alda-1 accelerates aldehyde degradation by activating ALDH2, reducing BDL-induced liver necrosis, inflammation, and fibrosis, indicating that aldehydes play an important role in the pathogenesis of cholestatic liver injury and fibrosis.	Free Radic Biol Med. 2019 Dec;145:136-145
Mice	GSNO-R−/− mice	Perfusion	20 μmol/L	10 minutes prior to the onset of ischemia and for 10 minutes at the start of reperfusion	Alda-1 significantly reduced infarct size in female GSNO-R?/? hearts, suggesting that excess mitochondrial formaldehyde may exacerbate I/R injury in female hearts with the disruption of GSNO-R.	Circ Res. 2018 Nov 9;123(11):1232-1243
C57BL/6J mice	Alcoholic liver disease model	Intraperitoneal injection	5 mg/kg	Every other day for 10 days	To test the therapeutic potential of Alda-1 for alcoholic liver disease, results showed that Alda-1 treatment alleviated liver damage, reduced hepatic steatosis, and apoptosis.	J Hepatol. 2015 Jun;62(6):1375-81.
C57BL/6J mice	GFP-LC3 transgenic mice	Intraperitoneal injection	50 mg/kg	Single dose	Alda-1 pretreatment reduced ethanol-induced mitochondrial depolarization and GFP-LC3 puncta formation.	Autophagy. 2022 Nov;18(11):2671-2685

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed